Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hibernation therapy for moderate to severe psoriasis
ChiCTR1900022721Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Apr 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of scopolamine and propofol in psoriasis (3 arms), sponsored by Ruijin Hospital. Primary endpoint: PASI score. Started Apr 2019; status: recruiting.
02
Drugs
scopolaminepropofol
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR1900022721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022721.